<p>The study investigates the therapeutic potential of <i>Acacia catechu</i>, a medicinal plant, in the context of inflammatory bowel disease, specifically Crohn’s disease. Utilizing a rat model, the research evaluates the protective effects of both standard extracts and nano formulations of <i>Acacia catechu</i> against colonic damage induced by dextran sulfate sodium. The methodology includes extracting active compounds from the bark of <i>Acacia catechu</i>, followed by pharmacological assessments of antioxidant enzyme activities and histopathological evaluations. Results indicate that the standard extract and nano formulation significantly improve colon health, as evidenced by enhanced colon weight-to-length ratios, better stool consistency, and reduced tissue damage compared to control groups. The antioxidant properties of <i>Acacia catechu</i>, attributed to its bioactive compounds, play a crucial role in mitigating oxidative stress and inflammation. The study highlights the potential of nano formulations of <i>Acacia catechu</i> to enhance the bioavailability of these compounds, suggesting a promising avenue for developing effective treatments for Inflammatory bowel disease. Overall, the findings support the integration of <i>Acacia catechu</i> into therapeutic strategies for managing chronic inflammatory conditions, warranting further research to validate these effects in human populations.</p>